Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma
- 1 November 1997
- journal article
- Published by Elsevier BV in Molecular Immunology
- Vol. 34 (16-17), 1157-1165
- https://doi.org/10.1016/s0161-5890(97)00144-2
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- A Combinatorial Library Strategy for the Rapid Humanization of Anticarcinoma BR96 FabJournal of Biological Chemistry, 1996
- In vitro and in vivo antitumour activity of a chimeric anti-CD19 antibodyCancer Immunology, Immunotherapy, 1995
- Recent developments in immunotoxin therapyCurrent Opinion in Immunology, 1994
- Guiding the Selection of Human Antibodies from Phage Display Repertoires to a Single Epitope of an AntigenNature Biotechnology, 1994
- Comparison of Surface Accessible Residues in Human and Murine Immunoglobulin Fv Domains: Implication for Humanization of Murine AntibodiesJournal of Molecular Biology, 1994
- Technetium‐99 m labelling of DD‐3B6/22 antifibrin monoclonal antibody fragment Fab′ for thrombus imagingImmunology & Cell Biology, 1993
- Antibody Conjugates for the Treatment of CancerImmunological Reviews, 1992
- Preparation and characterization of a chimeric CD 19 monoclonal antibodyImmunology & Cell Biology, 1991
- Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibodyCancer Immunology, Immunotherapy, 1991
- REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1HThe Lancet, 1988